James E Stefano

This inventor holds 29 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Glycoengineering Therapeutics. Top assignees: Genzyme Corporation, Amoco Corporation, Sanofi. Active years: 1995-2025.

USPTO Granted Patents = 29 (Patent Applications = 4)

% Patents Active = 89.7

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 254(Granted Patents)

Location History:

Bridgewater, NJ (US) (2019 - 2020)
Cambridge, MA (US) (2020 - 2021)
Hopkinton, MA (US) (1995 - 2022)

Company Filing History:

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Oligosaccharide-Protein Conjugates

Antibody-Drug Conjugation

Bone-Targeting Antibodies

GLP-1 Dual Agonist

Glycoprotein Therapeutics

Peptide Analogs

VEGF Antagonist Compositions

Nucleic Acid Structures

Selective Amplification

Catalytic Replication

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12252504 - Oligosaccharide-protein conjugates (2025-03-18),

2. 12110338 - Site-specific antibody-drug conjugation through glycoengineering (2024-10-08),

3. 12098194 - Bone-targeting antibodies (2024-09-24),

4. 11279725 - Oligosaccharide-protein conjugates (2022-03-22),

5. 11141489 - Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid (2021-10-12),

6. 11130816 - Site-specific antibody-drug conjugation through glycoengineering (2021-09-28),

7. 10844115 - Bone-targeting antibodies (2020-11-24),

8. 10806797 - Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate (2020-10-20),

9. 10792367 - Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic acid (2020-10-06),

10. 10792342 - Targeting of glycoprotein therapeutics (2020-10-06),

11. 10464962 - Oligosaccharide-protein conjugates (2019-11-05),

12. 10385108 - Peptide analogs of alpha-melanocyte stimulating hormone (2019-08-20),

13. 10308917 - Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof (2019-06-04),

14. 10214589 - Site-specific antibody-drug conjugation through glycoengineering (2019-02-26),

15. 9738698 - Peptide analogs of alpha-melanocyte stimulating hormone (2017-08-22),

Title: The Innovative Journey of James E Stefano

Introduction: James E Stefano, a talented inventor based in Hopkinton, MA (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: James E Stefano holds several patents in various technological domains, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With a career spanning over two decades, James E Stefano has consistently pushed the boundaries of technology with his inventive solutions. His passion for innovation has led to the development of cutting-edge products that have revolutionized the industry.

Collaborations: Throughout his career, James E Stefano has collaborated with leading tech companies, research institutions, and universities to bring his ideas to life. These collaborations have not only enhanced his inventions but have also paved the way for future technological advancements.

Conclusion: James E Stefano's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His remarkable contributions continue to inspire aspiring inventors and shape the future of technology.